Word

JERINI

Status

Dead

Status Code

710

Status Date

Friday, May 20, 2011

Serial Number

76272025

Registration Number

2894095

Registration Date

Tuesday, October 19, 2004

Mark Type

1000

Filing Date

Friday, June 15, 2001

Published for Opposition

Tuesday, July 27, 2004

Cancellation Date

Friday, May 20, 2011

Trademark Owner History

RUDOWER CHAUSSEE 29 12489 - Original Registrant
Jerini Bio Tools GmbH - Original Applicant

Classifications

1 Chemicals used in industry and science, agriculture, horticulture and forestry, namely, proteins, peptides, peptidomimetics, small molecules, nucleic acids and polynucleotides; proteins and recombinant proteins for scientific research use; peptides for scientific research use; antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antisense constructs for scientific research use; arrays of nucleic acids on a carrier material for scientific research use; arrays of proteins on a carrier material for scientific research use; arrays of peptides on a carrier material for scientific research use

5 Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolytics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastrointestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations, veterinary preparations for use in the treatment of diseases of pets, livestock, wild animals, breeding animals and zoo animals; dietic supplements adapted for medical use, namely food for elderly people and for medically restricted diets; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic use; fungicides for agricultural use; herbicides for domestic use; herbicides for agricultural use; medicaments against artheriosclerosis; medicaments against restenosis; medicaments for tissue regeneration and tissue replacement; medicaments for cartilage regeneration; pharmaceutical and veterinary preparations for diabetes treatment; pharmaceutical and veterinary preparations for diabetes prophylaxis; medicaments against obesity; pharmaceutical and veterinary preparations for use in pets, livestock, wild animals, breeding animals and zoo animals against tumors; peptides for medical use; peptides for medical diagnostic use; peptidomimetics for medical use; peptiomimetics for medical diagnostic use; antibodies for medical use; antibodies for medical diagnostic use; DNA probes for medical use; DNA probes for medical diagnostic use; oligonucleotides for medical use; oligonucleotides for medical diagnostic use; small molecules for medical use

9 Scientific control apparatus and instruments, namely microscopes, ELISA readers, scanners, fluorescence readers, and phosphorimagers; scientific measuring and checking apparatus and instruments, comprising filters and membranes used in the field of biotechnology and pharmaceuticals; computer programs for synthesis of chemicals used in industry and science; computer programs for immobilization of chemicals used in industry and science; computer programs for analysis of patterns on surfaces, namely for analysis of filters and membranes; computer programs for the screening of compounds

40 Chemical processing or transformation of inorganic or organic compounds for third parties, namely synthesis of peptides, polypeptides and proteins, manufacture of immobilized enzyme substrates, proteinmimetica and peptidimimetica, synthesis of peptides with sterically hindered amino acids, synthesis of peptides with distinct secondary structures and/or multiple antigenic peptides, immobilization of products and compounds, compound libraries, enzyme substrates, proteinmimetica and peptidomimetica, modification of peptides and proteins, and transformation of biologically active peptides and peptidomimetica

42 Laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, medical doctor, protein chemist; scientific and industrial research; computer programming

Trademark Events

May 20, 2011

Cancelled Sec. 8 (6-Yr)

Feb 3, 2010

Attorney Revoked And/Or Appointed

Feb 3, 2010

Teas Revoke/Appoint Attorney Received

Oct 24, 2007

Review Of Correspondence Complete

Oct 18, 2007

Paper Received

Dec 11, 2004

Teas Change Of Correspondence Received

Nov 8, 2004

Paper Received

Nov 9, 2004

Paper Received

Oct 19, 2004

Exparte Appeal Terminated

Oct 19, 2004

Registered-Principal Register

Jul 27, 2004

Published For Opposition

Jul 19, 2004

Paper Received

Jul 7, 2004

Notice Of Publication

Jun 18, 2004

Paper Received

Apr 20, 2004

Approved For Pub - Principal Register

Apr 20, 2004

Sec. 1(B) Claim Deleted

Apr 20, 2004

Correspondence Received In Law Office

Mar 5, 2004

Fax Sent

Feb 25, 2004

Paper Received

Feb 17, 2004

Non-Final Action Mailed

Jan 23, 2004

Case File In Ticrs

Jan 20, 2004

Jurisdiction Restored To Examining Attorney

Jan 20, 2004

Ex Parte Appeal-Instituted

Jan 12, 2004

Exparte Appeal Received At Ttab

Sep 11, 2003

Paper Received

Mar 12, 2003

Final Refusal Mailed

Feb 3, 2003

Correspondence Received In Law Office

Feb 3, 2003

Paper Received

Jan 15, 2003

Inquiry As To Suspension Mailed

Mar 11, 2002

Correspondence Received In Law Office

Jun 18, 2002

Letter Of Suspension Mailed

Mar 12, 2002

Correspondence Received In Law Office

Mar 1, 2002

Correspondence Received In Law Office

Mar 11, 2002

Paper Received

Mar 1, 2002

Paper Received

Aug 27, 2001

Non-Final Action Mailed

Aug 20, 2001

Assigned To Examiner